The Montreal General Hospital is a hospital in Montreal, Quebec, Canada was established in the years 1818-1820. The hospital received its charter in 1823. It is currently part of the McGill University Health Centre and is located on Mount Royal, at the intersection of Pine Avenue and Côte-des-Neiges Road.

There are 479 beds in Montreal General Hospital.

During the past decade, Montreal General Hospital conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 29 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal General Hospital" #1 sponsor was "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 39 trials, followed by "NSABP Foundation Inc" with 16 trials sponsored, "Franco Carli" with 8 trials sponsored, "McGill University" with 5 trials sponsored and "Ontario Clinical Oncology Group (OCOG)" with 5 trials sponsored. Other sponsors include 108 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 13 trials as a collaborator, "Montreal General Hospital" with 4 trials as a collaborator, "University of Toronto" with 4 trials as a collaborator and "Jewish General Hospital" with 3 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Montreal General Hospital" are "Breast Cancer" (18 trials), "HIV Infections" (14 trials), "Parkinson's Disease" (6 trials), "Prostate Cancer" (6 trials) and "Colon Cancer" (5 trials). Many other conditions were trialed in "Montreal General Hospital" in a lesser frequency.

Most popular intervention types in "Montreal General Hospital" are "Drug" (95 trials), "Other" (36 trials), "Procedure" (29 trials), "Device" (18 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "cyclophosphamide" (7 trials), "Cyclophosphamide" (6 trials), "Docetaxel" (5 trials) and "Lamivudine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Montreal General Hospital" are 149 trials for "All" genders, 28 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Montreal General Hospital". 1 are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 121 completed trials in Montreal General Hospital, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal General Hospital, 5 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 61 trials that are defined as “Not Applicable".